BAY2862789

N/A

Report date: 2024/06/04 16:17:16
NME

Base Information

Drug NameBAY2862789
Drug Alias NameBAY2862789BAY-2862789
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol kinase alpha inhibitors
TargetsDiacylglycerol kinase alpha
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIsrael +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGBayer Healthcare Company Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A